CRDF icon

Cardiff Oncology
CRDF

Overview Fund Trends Analyst Outlook Journalist POV

55 hedge funds and large institutions have $11.6M invested in Cardiff Oncology in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

85% less call options, than puts

Call options by funds: $37K | Put options by funds: $251K

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$37K
Puts
$251K
Net Calls
Net Calls Change

Top Buyers

1
+$1.07M
2
+$355K
3
+$78K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$68.4K
5
Group One Trading
Group One Trading
Illinois
+$36.5K

Top Sellers

1
-$1.05M
2
-$314K
3
-$264K
4
Mercer Global Advisors
Mercer Global Advisors
Colorado
-$207K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$138K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$165
52
$134
53
$79
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
1 2
3